Showing results (271-280 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|July 2, 2024
Efficacy and safety of NTRK inhibitors in patients with NTRK fusion-positive lung and thyroid cancersDavid S Hong, Alexander Drilon, Lori J WirthClinical Advances in Hematology & Oncology : H&O|July 8, 2014
The role of tyrosine kinase inhibitors in hepatocellular carcinomaSunnie Kim, Ghassan K Abou-AlfaClinical Advances in Hematology & Oncology : H&O|June 9, 2021
Are novel agents ready to assume the mantle in the frontline treatment of mantle cell lymphoma?Samuel Yamshon, Peter MartinClinical Advances in Hematology & Oncology : H&O|October 3, 2015
New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine TumorsAlexandria T Phan, Pamela L Kunz, Diane L Reidy-LagunesClinical Advances in Hematology & Oncology : H&O|October 10, 2015
New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspectiveFabienne McClanahan, John GribbenClinical Advances in Hematology & Oncology : H&O|September 10, 2015
Families with both Hodgkin lymphoma and multiple myeloma in their pedigreesPeter H Wiernik, Dona Wickramasinghe, Janice P DutcherClinical Advances in Hematology & Oncology : H&O|April 9, 2016
PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancerStephen J Bagley, Joshua M Bauml, Corey J LangerClinical Advances in Hematology & Oncology : H&O|April 9, 2016
Should all patients with SCLC receive prophylactic cranial irradiation if they have responded to treatment? PCI should be offered in nearly all casesBen J SlotmanClinical Advances in Hematology & Oncology : H&O|April 9, 2016
Programmed death 1 immune checkpoint inhibitorsMeghna S Trivedi, Brianna Hoffner, Jennifer L Winkelmann, et al.Clinical Advances in Hematology & Oncology : H&O|July 28, 2017
Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtypeJulia Wells, Nitin Jain, Marina KonoplevaPageof 68